Thomas Edward Hughes

This inventor holds 15 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Zafgen, Inc., Vanderbilt University, Novartis Ag. Active years: 2011-2019.

USPTO Granted Patents = 15 (Patent Applications = 22)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 1.7

ph-index = 7

Forward Citations = 155(Granted Patents)

Location History:

Concord, MA (US) (2011 - 2014)
Boston, MA (US) (2015 - 2019)

Company Filing History:

Vanderbilt University

where one patent can have more than one assignee

Years Active: 2011-2019

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10406134 - Methods of treating an overweight subject (2019-09-10),

2. 10231946 - Methods of treating ischemic organ damage and other disorders (2019-03-19),

3. 10064839 - Methods of treating liver diseases (2018-09-04),

4. 9849106 - Methods of treating impaired wound healing (2017-12-26),

5. 9649293 - Methods of treating an overweight subject (2017-05-16),

6. 9597309 - Methods of treating renal disease and other disorders (2017-03-21),

7. 9561209 - Methods of treating liver diseases (2017-02-07),

8. 9446016 - Methods of treating age related disorders (2016-09-20),

9. 9173865 - Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol (2015-11-03),

10. 9000035 - Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol (2015-04-07),

11. 8980946 - Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol (2015-03-17),

12. 8642650 - Methods of treating an overweight or obese subject (2014-02-04),

13. 8367721 - Methods of treating an overweight or obese subject (2013-02-05),

14. 8143217 - Use of DPP-IV inhibitor to reduce hypoglycemic events (2012-03-27),

15. 7935723 - Use of organic compounds (2011-05-03),

Title: Thomas Edward Hughes: Innovator in Medical Treatments

Introduction

Thomas Edward Hughes is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of medical treatments, holding a total of 15 patents. His work primarily focuses on methods that address weight loss and organ damage, showcasing his commitment to improving patient health.

Latest Patents

Among his latest patents, Hughes has developed innovative methods for treating overweight subjects. This invention relates to administering a MetAP2 inhibitor to effect weight loss and improve glucose tolerance in patients in need. Additionally, he has created methods for treating ischemic organ damage and other disorders. This invention targets patients suffering from renal disorders or related issues, utilizing effective amounts of a MetAP-2 inhibitor to address low levels of sRAGE and adiponectin.

Career Highlights

Hughes has worked with notable organizations, including Zafgen, Inc. and Vanderbilt University. His career reflects a dedication to advancing medical science and improving treatment options for patients.

Collaborations

Some of his notable coworkers include James E. Vath and Alan Cherrington. Their collaborative efforts have contributed to the success of Hughes' inventions and research.

Conclusion

Thomas Edward Hughes stands out as an influential inventor in the medical field, with a focus on innovative treatments that enhance patient care. His contributions continue to impact the lives of many individuals seeking effective medical solutions.